期刊文献+

肝过表达hNPC1L1促进脂质过氧化

Overexpression of human Niemann-Pick C1-Like 1 in livers accelerates lipid peroxidation
下载PDF
导出
摘要 利用体细胞核移植技术将构建的肝过表达h NPC1L1的小型猪胎儿成纤维细胞作为核供体细胞,构建了肝过表达h NPC1L1转基因巴马小型猪,PCR和RT-PCR鉴定表明h NPC1L1特异性地表达于肝组织。对转基因巴马小型猪进行了初步研究,脂质过氧化标记物丙二醛(MDA)检测表明:转基因猪MDA含量(7.51±0.09)nmol·m L-1显著高于非转基因猪(3.56±0.16)nmol·m L-1(P<0.001),说明肝组织发生了严重的脂质过氧化。超氧化物歧化酶(SOD)活性检测表明:SOD活性为(131±4.61)U·mg-1显著低于非转基因猪[(229.2±4.39)U·mg-1](P<0.001),说明肝脏清除自由基和抗氧化能力大大下降。试验揭示出在肝脏过表达h NPC1L1导致严重的脂质过氧化,表明NPC1L1在脂代谢紊乱和肝脏疾病中扮演着重要的角色,有望成为肝脏疾病治疗新的靶标。 The transgenic Bama miniature pigs in which human Niemann-Pick C1-Like 1( h NPC1 L1) was overexpressed in the livers were constructed by using somatic cell nuclear transfer technique with the minipig fetal fibroblast cells as the nuclear donor cells. The h NPC1 L1 was specifically expressed in transgenic liver tissues as revealed by PCR and reverse transcriptase( RT)-PCR analysis. A preliminary study on transgenic Bama miniature pigs was carried out,and the marker malondialdehyde( MDA) of lipid peroxidation was detected. The result showed that the level of MDA in transgenic pigs [( 7. 51 ± 0. 09) nmol·m L-1]was significantly higher than that in non-transgenic pigs[( 3. 56 ± 0. 16) nmol·m L-1]( P 0. 001),but SOD level in transgenic pigs [( 131 ± 4. 61) U·mg-1]was significantly lower than that in non-transgenic pigs [( 229. 2 ± 4. 39) U·mg-1]( P 0. 001). All of these suggested that severe lipid peroxidation occurred in the liver and the oxygen free radical scavenging and antioxidant capacity weresignificantly reduced. This study revealed that overexpression of NPC1 L1 in the liver led to severe lipid peroxidation,which indicated that NPC1 L1 played an important role in lipid metabolism disorders and liver diseases and could be a new target for liver disease treatment.
出处 《浙江农业学报》 CSCD 北大核心 2017年第10期1654-1660,共7页 Acta Agriculturae Zhejiangensis
基金 国家科技支撑计划(2011BA115B02)
关键词 hNPC1L1 过表达 体细胞核移植 脂质过氧化 human Niemann-Pick C1-Like 1 overexpression somatic cel l nuclear transfer lipid peroxidation
  • 相关文献

参考文献1

二级参考文献53

  • 1[1]Willner IR,Waters B,Patil SR,Reuben A,Morelli J,Riely CA.Ninety patients with nonalcoholic steatohepatitis:insulin resistance,familial tendency,and severity of disease.Am J Gastroenterol 2001; 96:2957-2961
  • 2[2]Bugianesi E,Leone N,Vanni E,Marchesini G,Brunello F,Carucci P,Musso A,De Paolis P,Capussotti L,Salizzoni M,Rizzetto M.Expanding the natural history of nonalcoholic steatohepatitis:from cryptogenic cirrhosis to hepatocellular carcinoma.Gastroenterology 2002; 123:134-140
  • 3[3]Angulo P.Nonalcoholic fatty liver disease.N Engl J Med 2002;346:1221-1231
  • 4[4]Assy N,Kaita K,Mymin D,Levy C,Rosser B,Minuk G.Fatty infiltration of liver in hyperlipidemic patients.Dig Dis Sci 2000; 45:1929-1934
  • 5[5]Green RM.NASH-hepatic metabolism and not simply the metabolic syndrome.Hepatology 2003; 38:14-17
  • 6[6]Angulo P,Keach JC,Batts KP,Lindor KD.Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.Hepatology 1999; 30:1356-1362
  • 7[7]Donnelly KL,Smith CI,Schwarzenberg SJ,Jessurun J,Boldt MD,Parks EJ.Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.J Clin Invest 2005; 115:1343-1351
  • 8[8]Tamura S,Shimomura I.Contribution of adipose tissue and de novo lipogenesis to nonalcoholic fatty liver disease.J Clin Invest 2005; 115:1139-1142
  • 9[9]Wanless IR,Shiota K.The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases:a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.Semin Liver Dis 2004; 24:99-106
  • 10[10]Maeda N,Shimomura I,Kishida K,Nishizawa H,Matsuda M,Nagaretani H,Furuyama N,Kondo H,Takahashi M,Arita Y,Komuro R,Ouchi N,Kihara S,Tochino Y,Okutomi K,Horie M,Takeda S,Aoyama T,Funahashi T,Matsuzawa Y.Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.Nat Med 2002; 8:731-737

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部